Neonatal and infant feeding disorders program saves infants from lifetime of feeding tubes

Innovative feeding strategy improves infant feeding and saves millions a year in health-care costs

 

Columbus, Ohio USA (September 6, 2011 – An innovative approach to treating neonatal feeding problems at Nationwide Children’s Hospital has allowed infants who were struggling to feed orally to be discharged earlier and without feeding tubes, subsequently saving millions of annual healthcare charges.

 

According to American Academy of Pediatrics guidelines, in order for premature infants to be discharged from the hospital, they must establish safe oral feeding methods. The prevalence of feeding problems in once-premature infants is twice that of full-term infants and often prolongs hospitalization for these babies. Infants who fail to gain skills necessary to feed orally often receive gastrostomy tubes, tubes placed within a baby’s stomach through which he/she can receive nutrition. For the first year, home gastrostomy feeding methods cost nearly $47,000.

 

The study, appearing in the Journal of Pediatric Gastroenterology and Nutrition, details outcomes for 100 neonatal intensive care unit (NICU) infants referred to the Neonatal and Infant Feeding Disorders Program at Nationwide Children’s for a feeding strategy in an effort to avoid gastrostomy placement. Their feeding capabilities were detailed at birth, at the time of feeding evaluation, at discharge and at 1 year of age.

 

Because they received an individualized feeding strategy, 51 percent of these infants were feeding successfully upon discharge and 84 percent at 1 year of age. Even among the gastrostomy infants, the vast majority of patients went on to recover significant oral motor skills.

 

The integrated feeding strategy led to a higher feeding success than traditional methods. Of 50 infants who received conventional treatment in years prior to the Neonatal and Infant Feeding Disorders Program, 10 percent were feeding orally at discharge and 42 percent at 1 year of age.

 

"Being able to successfully develop feeding strategies for these infants provides them a greatly improved quality of life, improves parental satisfaction and leads to a reduced economic burden," said Sudarshan Jadcherla, MD, FRCPI, DCH, AGAF, Nationwide Children’s Hospital neonatologist and principal investigator in the Center for Perinatal Research, medical director of the Neonatal and Infant Feeding Disorders Program at Nationwide Children’s and lead author of the study. Among the 100 infants in this study, there was an estimated $3.8 million cost savings over one year – $2.1 million in savings from avoided gastrostomy tube placement, $1.7 million in savings because of earlier discharge from the hospital.

 

Dr. Jadcherla, also professor of Pediatrics at The Ohio State University College of Medicine and Public Health, says the strength of the feeding strategy described in this study lies in the fact that it is multidisciplinary, individualized and evidence-based. First, clinicians documented each infant’s feeding difficulty symptoms and noted any underlying disease. Each infant underwent specialized pharyngo-esophageal manometry and swallow studies to evaluate the structure and function of his/her aerodigestive system. Further studies and input from a multidisciplinary team helped characterize the mechanisms of each infant’s feeding difficulty and their symptoms. These findings were discussed with parents. An individualized feeding management strategy was developed for each infant with special emphasis on feeding mechanics, feeding methods, co-morbidities, nutrition and growth. Finally, nurses, feeding therapists and parents were educated on the baby’s feeding plan.

 

"This is the first study to describe an innovative approach to diagnose feeding problems and implement management strategies to improve oral feeding outcomes at discharge and followed at 1-year, among complex NICU infants expected to receive gastrostomy tubes," said Dr. Jadcherla.

 

 

 

 


Nationwide Children’s Hospital, 06.09.2011 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…